Secura Bio Competitors and Similar CompaniesClear all
Secura Bio's competitors and similar companies include Prelude Therapeutics, Seagen, Dendreon and Mersana Therapeutics.
 Secura Bio Secura Bio is an integrated biopharmaceutical company dedicated to the commercialization of oncology therapies. |  Prelude Therapeutics Prelude Therapeutics is a biotechnology company that discovers and develops medicines targeting chromatin function to treat cancer and rare diseases. |  Seagen Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer. |  Dendreon Dendreon Pharmaceuticals (formerly known as Activated Cell Therapy) is a biopharmaceutical company that engages in the development of immunotherapy. |  Mersana Therapeutics Mersana Therapeutics is a clinical-stage biotechnology company developing antibody-drug conjugate (ADC) platforms. | |
Founding Date | Founding Date 2019 | Founding Date 2016 | Founding Date 1998 | Founding Date 1992 | Founding Date 2005 |
Type | Type Private | Type Private | Type Subsidiary | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Las Vegas, US HQ San Diego, US | Locations Wilmington, US HQ Canton, US | Locations Bothell, US HQ Mississauga, CA Hørsholm, DK Rueil Malmaison, FR München, DE Milano, IT Schiphol, NL see more | Locations Seal Beach, US HQ Seattle, US Union City, US Tampa, US | Locations Cambridge, US HQ |
Employees | Employees 489% increase | Employees 1372% decrease | Employees 3,25622% increase | Employees 6131% decrease | Employees 11033% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $2b (FY, 2022) | Revenue (est.) N/A | Revenue (est.) $40.5m (FY, 2024) |
Net income | Net income N/A | Net income N/A | Net income ($610.3m) (FY, 2022) | Net income N/A | Net income ($69.2m) (FY, 2024) |
Funding | |||||
Latest funding round | Latest funding round $ 55m (about 7 years ago) | Latest funding round $ 50m (over 5 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 195m | Total funding raised $ 122m | Total funding raised $ 164m | Total funding raised N/A | Total funding raised $ 219.5m |
For sources of this data, please see the company profile
View Company Profiles
Prelude Therapeutics
HQ
Wilmington, US
Employees
137↓ 2% decrease
Prelude Therapeutics is a biotechnology company that discovers and develops medicines targeting chromatin function to treat cancer and rare diseases.
View companySeagen
HQ
Bothell, US
Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer.
View companyDendreon
HQ
Seal Beach, US
Dendreon Pharmaceuticals (formerly known as Activated Cell Therapy) is a biopharmaceutical company that engages in the development of immunotherapy.
View companyMersana Therapeutics
HQ
Cambridge, US
Employees
110↑ 33% increase
Mersana Therapeutics is a clinical-stage biotechnology company developing antibody-drug conjugate (ADC) platforms.
View company